Mars' $36 billion Kellanova deal may lead to price hikes, EU regulators warn

Mars' $36 billion acquisition of Kellanova has been cleared by U.S. antitrust regulators, who found no anti-competitive concerns, allowing early termination of their review. Conversely, EU antitrust regulators have launched a full-scale investigation into the deal, citing concerns it could lead to price hikes and increase Mars' negotiating power with retailers, potentially necessitating divestitures or blocking the transaction. While Mars expressed disappointment with the EU's decision, it remains optimistic for a late 2025 closing, highlighting significant regulatory divergence and uncertainty for this major confectionery and snacking merger.

Analysis

The proposed $36 billion acquisition of Kellanova by Mars faces a significant regulatory divergence, creating material uncertainty for the deal's completion. While U.S. antitrust enforcers have granted an early termination of their review, concluding the transaction does not violate American competition law, their European Union counterparts have initiated a full-scale investigation. The FTC's clearance was based on a finding that the combined entity, which would hold approximately 12% of the U.S. snacking and candy market, would not sufficiently harm competition, given the presence of major rivals like PepsiCo, Mondelez, and Hershey. Conversely, the EU's probe is rooted in concerns that the merger could enhance Mars' negotiating power with retailers, potentially leading to consumer price hikes. This EU action introduces the primary risk to the transaction, potentially forcing Mars to divest certain assets or jeopardizing the deal entirely. Despite Mars expressing public optimism for a closing date towards the end of 2025, the EU investigation extends the timeline and elevates the risk profile for a deal previously viewed as having limited product overlap.

Key Decisions for Investors

• Investors in Kellanova (K) should recognize that the stock's performance is now heavily tied to the outcome of the EU's antitrust investigation, which introduces significant downside risk and timeline uncertainty not present with the U.S. clearance.
• The extended closing timeline to late 2025 increases the carrying cost and risk for merger-arbitrage positions, and the spread between Kellanova's market price and the acquisition price will likely remain volatile, reflecting developments from the EU probe.
• The conflicting regulatory stances between the U.S. and EU serve as a key case study for future M&A in the global consumer goods sector, highlighting that securing approval in one major jurisdiction does not guarantee a smooth path in others.